🧬 Medical Oncologist focused on breast cancer, lung cancer, oncofertility and cancer prevention📍Peter MacCallum Cancer Center, Australia
Joined November 2018
- Tweets195
- Following235
- Followers435
- Likes783
Wanda (Wanyuan) Cui retweeted
Read the latest research from the Christie lab @PeterMacRes on MHCII and whole genome duplication in ovarian cancer, published with @SpringerNature in @NatureComms nature.com/articles/s41467-0…
Wanda (Wanyuan) Cui retweeted
Delighted to see this really important step forward in the care of women with cancer: ovarian toxicity assessment must be standard in oncology trials. Great work from @ASCO led by @cuiwanda and Kelly-Anne Philips
Our new recommendations published today in @TheLancetOncol spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ brnw.ch/21wD8V4 #OncTwitter
Wanda (Wanyuan) Cui retweeted
Incredible collaborative effort across regulatory agencies, industry, academic and community oncology to assess #ovariantoxicity in clinical trials @rodrocconi @ramyathota1 @wandacui @SuparnaWedam @matteolambe #survivorship
Our new recommendations published today in @TheLancetOncol spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ brnw.ch/21wD8V4 #OncTwitter
Wanda (Wanyuan) Cui retweeted
So proud to be a part of these important recommendations. Goal is to improve the quality of life for many women with cancer #qol #ovariantoxicity
Our new recommendations published today in @TheLancetOncol spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ brnw.ch/21wD8V4 #OncTwitter
Wanda (Wanyuan) Cui retweeted
See here for the paper: thelancet.com/journals/lanon…
Our new recommendations published today in @TheLancetOncol spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ brnw.ch/21wD8V4 #OncTwitter
Wanda (Wanyuan) Cui retweeted
Assessing ovarian toxicity in clinical trials is way overdue! 🪺 We’re so proud of these recommendations published in @TheLancetOncol
Check them out here 👉🏼 thelancet.com/journals/lanon…
Our new recommendations published today in @TheLancetOncol spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ brnw.ch/21wD8V4 #OncTwitter
Wanda (Wanyuan) Cui retweeted
New @asco recommendations on the need for collection of ovarian toxicity in cancer clinical trials !
Our new recommendations published today in @TheLancetOncol spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ brnw.ch/21wD8V4 #OncTwitter
Wanda (Wanyuan) Cui retweeted
Knowing if a cancer treatment affects fertility or triggers early menopause is vital info for women and yet is rarely a focus of clinical trials. A new @ASCO statement - by @CuiWanda, @drkellyphillips and colleagues - aims to change this. More: petermac.org/about-us/news-a…
🚨 New @ASCO recommendations published in @TheLancetOncol. We need to better understand the impacts of cancer therapies on ovarian function so that patients have information about the risks to fertility and other longterm health implications from early menopause @drkellyphillips
Our new recommendations published today in @TheLancetOncol spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ brnw.ch/21wD8V4 #OncTwitter
Join me at #COSA23 in November, talking about cancer treatment related ovarian toxicity cosaasm.org.au
Wanda (Wanyuan) Cui retweeted
Absolute honour to work with the COSA Fertility Preservation Guidelines Working Group and publish our Perspective piece in the MJA today! 🌼 @COSAoncology @WCMICS @thewomens @UniMelbMDHS
Australian fertility preservation guidelines for people with cancer 2022 … #openaccess … "Best practice in oncofertility care requires structured referral pathways, with access to fertility preservation counselling and technology" ... mja.com.au/journal/2022/217/… #medtwitter
Wanda (Wanyuan) Cui retweeted
Can targeted anti #cancer therapies (vs traditional #chemotherapy) still cause #ovarian toxicity and #infertility ? Find out @Repro_Fertility (#OpenAccess) in this article by @RoseanneRosari0, @CuiWanda & @profdicanderson
➡️raf.bioscientifica.com/view/…
@horne_research @norahspears
Will be joining #teamTOGA to raise money for lung cancer research
Help me catch up to @reswong impressive fundraising effort using the link below 👇🏻
thoracic-oncology-group-of-a…
Our #TeamTOGA Melbourne contingent is up & running with @reswong turning in a fantastic weekend effort >$1.8K
The 3km walk entries are now open bit.ly/3CUtFF9
Set up yr fundraising page rb.gy/o1ot4w
Join our team of @DrMelMoore @CuiWanda Jackie Yoong...
#LCSM
Wanda (Wanyuan) Cui retweeted
So exciting to see this new work published on immunotherapy impacts to fertility @NatureCancer. This research strongly advocates we must include reproductive endpoints in clinical trials moving forward! nature.com/articles/s43018-0…
Wanda (Wanyuan) Cui retweeted
Immunotherapies are revolutionising cancer treatment.. but they raced into the clinic with some oversights of possible side effects. Our new data alerts women & clinicians to potential risks to fertility & highlights the need to prioritise human studies nature.com/articles/s43018-0…
An important study showing ICI causes ovarian tox in mice
❗️antiPDL1 & antiCTLA4 depleted primordial follicles by 50% & 46%
❗️increase in atretic secondary & antral follicles
We need to assess ovarian tox in trials!
@HuttLab @HuttKarla @amy_winship @LoiSher @drkellyphillips
➡️today @NatureCancer
1. we show in a preclinical model how checkpoint inhibitors can cause ovarian inflammation potentially affecting #fertility #bcsm @OncoAlert Gr8 work w @Huttlab 🙏 @sneha_sant @Lauren_Alesi @amy_winship @PeterMacRes @MonashBDI
👉rdcu.be/cUlAA
Wanda (Wanyuan) Cui retweeted
🎥 @CuiWanda of @PeterMacCC talks on improving target identification in patients with advanced NSCLC via up-front ctDNA
Watch: 👉ow.ly/4TpC50KiyFX👈
@IASLC #WCLC22 #LCSM #LungCancer
Wanda (Wanyuan) Cui retweeted
Delighted to have the opportunity to present our data @IASLC #WCLC22 on the frequency and detectability of uncommon EGFR mutations. PCR methods may miss 30% of cases. @SuzanneMacmahon @CuiWanda @drMaryOBr @DrSanjayPopat
Congratulations @HazelOSulliva14 for a brilliant talk, highlighting the limitations of EGFR PCR assays in detecting actionable “rare” (but actually not so rare!) EGFR variants and the importance of NGS testing for adequate target identification #WCLC2022 #iaslc
